Clinical Trial Update: A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase I study evaluating the safety and pharmacokinetics of [18F]Florbetazine Injection in participants with mild cogni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• [18F]Florbetazine Injection (Florbetazine)

Snippet

Sponsor: HTA Co., Ltd. | Conditions: MCI, AD | Phase 1 | Status: COMPLETED